Research in NSCLC indicates that the analysis of PD-L1 expression on CTCs (PD-L1+CTCs) is a potential factor in overcoming the tumor biopsy spatiotemporal heterogeneity of PD-L1 expression (103). This evidence concerns the gene CD274 and neoplasm.